Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. (SHE:301617)
China flag China · Delayed Price · Currency is CNY
73.64
+0.19 (0.26%)
At close: Feb 13, 2026

SHE:301617 Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Operating Revenue
1,3921,3261,021796.66523.69378.93
Other Revenue
2.012.013.681.820.680.52
1,3941,3281,025798.47524.37379.44
Revenue Growth (YoY)
8.45%29.53%28.39%52.27%38.20%12.16%
Cost of Revenue
1,095999.05739.4520.8347.04265.33
Gross Profit
299.78328.83285.75277.67177.33114.12
Selling, General & Admin
47.2343.1337.4736.8529.9223.14
Research & Development
53.5241.3435.6730.4821.4214.55
Other Operating Expenses
-1.71-3.06-0.783.231.21-0.43
Operating Expenses
99.7981.2876.1270.3452.4438.76
Operating Income
199.99247.55209.64207.33124.8975.36
Interest Expense
--0.03-0-0.46-1.97-3.05
Interest & Investment Income
5.673.241.140.510.136.42
Currency Exchange Gain (Loss)
-1.18-1.180.110.35-0.02-0.26
Other Non Operating Income (Expenses)
-3.33-0.33-0.15-0.52-0.18-0.3
EBT Excluding Unusual Items
201.14249.25210.74207.21122.8578.17
Gain (Loss) on Sale of Investments
-0.63-4.58-2.31-1.85-1.4-
Gain (Loss) on Sale of Assets
0.1-0.03-0.34--0.03
Asset Writedown
-0.03--0.55-4.39-3.77-6.17
Pretax Income
200.58244.64207.88201.31117.6971.97
Income Tax Expense
25.7131.5225.7824.9914.47.93
Net Income
174.86213.13182.1176.32103.2964.04
Net Income to Common
174.86213.13182.1176.32103.2964.04
Net Income Growth
-16.43%17.04%3.28%70.70%61.30%269.30%
Shares Outstanding (Basic)
1431001001009695
Shares Outstanding (Diluted)
1431001001009695
Shares Change (YoY)
72.29%0.07%0.08%4.17%0.84%-
EPS (Basic)
1.222.121.821.761.070.67
EPS (Diluted)
1.222.121.821.761.070.67
EPS Growth
-51.50%16.95%3.19%63.88%60.41%-
Free Cash Flow
-67.31105.6179.2653.911.5811.08
Free Cash Flow Per Share
-0.471.050.790.540.120.12
Dividend Per Share
0.4310.462----
Gross Margin
21.50%24.76%27.87%34.78%33.82%30.08%
Operating Margin
14.34%18.64%20.45%25.97%23.82%19.86%
Profit Margin
12.54%16.05%17.76%22.08%19.70%16.88%
Free Cash Flow Margin
-4.83%7.95%7.73%6.75%2.21%2.92%
EBITDA
229.51274.78233.82228.5144.291.33
EBITDA Margin
16.46%20.69%22.81%28.62%27.50%24.07%
D&A For EBITDA
29.5227.2324.1821.1719.3115.97
EBIT
199.99247.55209.64207.33124.8975.36
EBIT Margin
14.34%18.64%20.45%25.97%23.82%19.86%
Effective Tax Rate
12.82%12.88%12.40%12.41%12.23%11.02%
Advertising Expenses
-1.0110.460.210.09
Source: S&P Global Market Intelligence. Standard template. Financial Sources.